ED
45
3
MCO
71
-7
BA
47
2
CMS
60
2
HCP
56
-8
HSIC
45
5
HIG
66
2
INTU
58
-3
MAS
52
-4
MDLZ
32
-4
COP
57
-2
DG
8
-2
LB
30
4
PEP
39
-9
THC
60
-5
SIG
44
-3
JWN
48
-2
SPG
60
2
EXPD
43
-4
EA
60
-5
ED
45
3
MCO
71
-7
BA
47
2
CMS
60
2
HCP
56
-8
HSIC
45
5
HIG
66
2
INTU
58
-3
MAS
52
-4
MDLZ
32
-4
COP
57
-2
DG
8
-2
LB
30
4
PEP
39
-9
THC
60
-5
SIG
44
-3
JWN
48
-2
SPG
60
2
EXPD
43
-4
EA
60
-5
Financhill
Back

Franklin U.S. Low Volatility Hi Div ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
45

LVHD
Franklin U.S. Low Volatility Hi Div ETF

Last Price:
39.86
Seasonality Move:
2.53%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
45
Franklin U.S. Low Volatility Hi Div ETF (LVHD) is a Sell

Is Franklin U.S. Low Volatility Hi Div ETF a Buy, Sell or Hold?

  • The current Franklin U.S. Low Volatility Hi Div ETF [LVHD] share price is $39.86. The Score for LVHD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • LVHD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LVHD Stock Price Chart

What is Franklin U.S. Low Volatility Hi Div ETF's stock price today?

  • The Franklin U.S. Low Volatility Hi Div ETF share price today is $39.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LVHD is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

LVHD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 44.71 Sell
Chaikin Money Flow: -5734 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.83 - 40.81) Sell
Bollinger Bands (100): (37.58 - 40.72) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

LVHD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.11 Sell
20-day SMA: 40.14 Sell
50-day SMA: 40.35 Sell
200-day SMA: 37.48 Buy
8-day EMA: 40.05 Sell
20-day EMA: 40.14 Sell
50-day EMA: 40 Sell
200-day EMA: 38.16 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Franklin U.S. Low Volatility Hi Div ETF Earnings Growth & LVHD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Franklin U.S. Low Volatility Hi Div ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):